Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
Top Cited Papers
- 14 August 2013
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (36), E3445-54
- https://doi.org/10.1073/pnas.1303002110
Abstract
Stapled α-helical peptides have emerged as a promising new modality for a wide range of therapeutic targets. Here, we report a potent and selective dual inhibitor of MDM2 and MDMX, ATSP-7041, which effectively activates the p53 pathway in tumors in vitro and in vivo. Specifically, ATSP-7041 binds both MDM2 and MDMX with nanomolar affinities, shows submicromolar cellular activities in cancer cell lines in the presence of serum, and demonstrates highly specific, on-target mechanism of action. A high resolution (1.7-Å) X-ray crystal structure reveals its molecular interactions with the target protein MDMX, including multiple contacts with key amino acids as well as a role for the hydrocarbon staple itself in target engagement. Most importantly, ATSP-7041 demonstrates robust p53-dependent tumor growth suppression in MDM2/MDMX-overexpressing xenograft cancer models, with a high correlation to on-target pharmacodynamic activity, and possesses favorable pharmacokinetic and tissue distribution properties. Overall, ATSP-7041 demonstrates in vitro and in vivo proof-of-concept that stapled peptides can be developed as therapeutically relevant inhibitors of protein-protein interaction and may offer a viable modality for cancer therapy.Keywords
This publication has 47 references indexed in Scilit:
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism studyThe Lancet Oncology, 2012
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerizationProceedings of the National Academy of Sciences, 2012
- An orthosteric inhibitor of the Ras-Sos interactionNature Chemical Biology, 2011
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53Cancer Cell, 2010
- The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizerNature Chemical Biology, 2010
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMXJournal of Biological Chemistry, 2010
- Direct inhibition of the NOTCH transcription factor complexNature, 2009
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMXProceedings of the National Academy of Sciences, 2009
- Mdm2 promotes the rapid degradation of p53Nature, 1997